Corporate Compliance

Boston laboratory agrees to pay $629,000 in fraud settlement

Compliance Monitor, August 5, 2009

Boston Clinical Laboratories reached a settlement with authorities and agreed to pay $615,000 to the Massachusetts Medicaid program and $14,000 to the federal government for improperly billing for urine tests, according to a Department of Justice (DOJ) release.
 
According to the release, Massachusetts Attorney General Martha Coakley is conducting an industry-wide investigation of how independent laboratories, like Boston Clinical, bill for urine tests.
 
The complaint against Boston Clinical alleged the company billed the Massachusetts Medicaid program for more than 66,000 urine screenings that were ordered by an unauthorized prescriber. Some tests were also ordered for improper reasons, including residential sobriety monitoring.
 
Boston Clinical also agreed to hire an independent compliance monitor to create and execute compliance policies for the company, train all current and future employees on MassHealth compliance issues, and conduct bi-annual compliance audits. 

Most Popular